AngioGenex Inc., of New York, appointed William Garland to its board of directors and named Richard Salvador as its chairman.

Aradigm Corp., of Hayward, Calif., appointed Timothy Lynch to its board of directors.

BioCryst Pharmaceuticals Inc., of Birmingham, Ala., named Thomas J. Simon consultant and interim chief medical officer.

Biogen Idec, of Cambridge, Mass, appointed Nancy L. Leaming to its board of directors.

Cerimon Pharmaceuticals Inc., of San Francisco, named Matthew J. Meyer general counsel and vice president of business development and licensing.

ChemGenex Pharmaceuticals, of Menlo Park, Calif., named Julie Cherrington to its board of directors.